Shamrock Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$432K Sell
6,815
-339
-5% -$22.2K 0.34% 68
2019
Q2
$483K Buy
7,154
+198
+3% +$13K 0.34% 68
2019
Q1
$452K Buy
6,956
+26
+0.4% +$1.73K 0.36% 61
2018
Q4
$433K Hold
6,930
0.65% 48
2018
Q3
$535K Hold
6,930
0.34% 62
2018
Q2
$491K Hold
6,930
0.3% 74
2018
Q1
$470K Sell
6,930
-315
-4% -$25K 0.28% 76
2017
Q4
$519K Hold
7,245
0.31% 64
2017
Q3
$587K Sell
7,245
-115
-2% -$8.79K 0.38% 52
2017
Q2
$521K Sell
7,360
-176
-2% -$11.7K 0.33% 60
2017
Q1
$512K Buy
+7,536
New +$530K 0.32% 62
2016
Q3
Sell
-226
Closed -$19K 266
2016
Q2
$19K Buy
226
+50
+28% +$4.44K 0.01% 177
2016
Q1
$16K Sell
176
-186
-51% -$16.8K 0.01% 176
2015
Q4
$37K Hold
362
0.02% 150
2015
Q3
$36K Buy
362
+100
+38% +$11.1K 0.02% 137
2015
Q2
$31K Sell
262
-600
-70% -$65.6K 0.01% 159
2015
Q1
$85K Hold
862
0.03% 120
2014
Q4
$81K Sell
862
-335
-28% -$34.6K 0.03% 91
2014
Q3
$127K Buy
1,197
+100
+9% +$9.79K 0.05% 86
2014
Q2
$91K Sell
1,097
-51
-4% -$3.97K 0.03% 119
2014
Q1
$81K Buy
+1,148
New +$90K 0.03% 110

Other funds holding GILD

Shamrock Asset Management's GILD Position: Q3 2019 in Review

Shamrock Asset Management reduced its Gilead Sciences (GILD) stake by 4.7% in Q3 2019, selling an estimated $22.2K and leaving 6,815 shares worth $432K. The position accounts for 0.34% of the portfolio, ranked #68.

Shamrock Asset Management first reported a position in GILD in Q1 2014 and has held it in 21 quarters since. The position peaked at $587K in Q3 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Shamrock Asset Management held 6,815 shares of Gilead Sciences worth $432K as of Q3 2019.
  • Shamrock Asset Management sold 339 Gilead Sciences shares in Q3 2019, an estimated $22.2K.
  • Gilead Sciences made up 0.34% of Shamrock Asset Management's portfolio in Q3 2019, its #68 holding.
  • Shamrock Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 21 quarters since.
  • Shamrock Asset Management's Gilead Sciences position peaked at $587K in Q3 2017.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.